Publications

Home
Publications

Role of Lipids and Lipid Management Therapy Among Patients With Peripheral Artery Disease: A Reappraisal of the Current Evidence and Future Directions
Published on 2025-09-19 First Author McCall Walker
Association between lipoprotein(a) and cardiovascular events in patients with peripheral artery disease: the Mass General Brigham Lp(a) registry
Published on 2025-09-19 First Author Daniel J McClintick
Peripheral artery disease
Published on 2025-09-18 First Author Victor Aboyans
Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial
Published on 2025-09-10 First Author Brian G DeRubertis
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial
Published on 2025-09-04 First Author Subodh Verma
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants
Published on 2025-09-03 First Author Sean J Jurgens
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTOR
Published on 2025-09-02 First Author Faiez Zannad
Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events
Published on 2025-09-02 First Author Kausik K Ray
Sex Differences in Effectiveness of Semaglutide in Patients with Peripheral Artery Disease: The STRIDE Trial
Published on 2025-09-02 First Author Subodh Verma
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
Published on 2025-09-02 First Author Faiez Zannad
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
Published on 2025-09-02 First Author Javed Butler
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis
Published on 2025-09-01 First Author Stephen J Nicholls
Nonsteroidal and Steroidal Mineralocorticoid Antagonists: Rationale, Evidence, and Unanswered Questions
Published on 2025-08-31 First Author Josephine L Harrington
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial
Published on 2025-08-30 First Author Javed Butler
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk
Published on 2025-08-27 First Author Paul M Haller
Mobile integrated health for heart failure: insights from the MIGHTy-Heart trial
Published on 2025-08-25 First Author Christian Basile
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial
Published on 2025-08-23 First Author Gregory P Geba
Response to: 'A call for patient involvement in peripheral artery disease research priority setting'
Published on 2025-08-22 First Author Mary M McDermott
Temporal shift in prevalence of heart failure diagnoses and comorbidities within 2 US integrated health systems
Published on 2025-08-19 First Author Mario Enrico Canonico
Accuracy of Dexcom G6 Pro Continuous Glucose Monitor in the Intensive Care Setting: TIGHT ICU G6 Study
Published on 2025-08-13 First Author Jagdeesh Ullal
International BEST-CLI Collaborative: next steps to create a coordinated global initiative to improve awareness and access while reducing mortality and amputation for patients with chronic limb-threatening ischaemia
Published on 2025-08-12 First Author Michael B Strong
Cardiovascular Risk Factor and Disease Mortality Among Asian Indian, Chinese, and Filipino Adults in the United States, 2018 to 2023
Published on 2025-07-28 First Author Rahul Aggarwal
Digital Therapeutic Based Randomized Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy: Rationale, Design, and Baseline Characteristics of the BRIGHT Trial
Published on 2025-07-17 First Author Mario Enrico Canonico
First myocardial infarction: risk factors, symptoms, and medical therapy
Published on 2025-07-03 First Author Nick S Nurmohamed
Health Care Resource Utilization and Costs of Major Adverse Thrombotic Events in Patients with and without ESKD
Published on 2025-06-23 First Author Nicholas S Roetker
Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial
Published on 2025-06-21 First Author Neda Rasouli
Exercise therapy for symptomatic peripheral artery disease following lower-extremity revascularization in two large healthcare systems
Published on 2025-06-16 First Author Shea E Hogan
Pathways for international medical graduates in U.S. general surgery residency programs: Obstacles and opportunities to overcome them
Published on 2025-06-12 First Author Ioannis A Ziogas
Moving Beyond Glycated Hemoglobin to Glucose Patterns: Newer Indications for Continuous Glucose Monitor Use
Published on 2025-06-06 First Author Shubham Agarwal
Continuous Glucose Monitoring for Prediabetes: Roles, Evidence, and Gaps
Published on 2025-05-23 First Author Salwa J Zahalka
Heart failure with preserved ejection fraction therapeutics: in search of the pillars
Published on 2025-05-21 First Author Abdelghani El Rafei
Dexcom G7 Accuracy and Reproducibility in the Intensive Care Unit
Published on 2025-05-13 First Author Jesica D Baran
Preserving Trial Endpoint Specificity and Cause of Death Attribution in Cardiovascular Trials: Insights From MARINER
Published on 2025-05-13 First Author Shea E Hogan
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
Published on 2025-05-08 First Author Stephen J Nicholls
Research priorities for peripheral artery disease: A statement from the Society for Vascular Medicine
Published on 2025-05-01 First Author Mary M McDermott
Hypertension in atherosclerotic cardiovascular disease: insights into epidemiology, management strategies, and outcomes
Published on 2025-04-30 First Author Prerna Gupta
Prescription of aspirin plus low-dose rivaroxaban in patients with peripheral artery disease after lower-extremity revascularization
Published on 2025-04-30 First Author Mario Enrico Canonico
Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population
Published on 2025-04-15 First Author Rahul Aggarwal
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence
Published on 2025-04-14 First Author Mario Enrico Canonico
Virta Intervention in CommuniTies in ColORado (VICTOR) Pilot Study to Improve Diabetes and Cardiovascular Risk in Rural Communities - Primary Results
Published on 2025-04-10 First Author Cecilia C Low Wang
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
Published on 2025-04-07 First Author P Gabriel Steg
Correction to: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published on 2025-04-07 First Author Heather L Gornik
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
Published on 2025-04-01 First Author Marc P Bonaca
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial
Published on 2025-03-21 First Author R Kevin Rogers
Predictors of venous thromboembolic events in hospitalized patients with COVID-19
Published on 2025-03-11 First Author Giovanni Scimeca
Apolipoprotein C3, triglycerides, and cardiovascular risk in optimally treated ACS patients: The critical role of mediation analysis and implications for precision primary prevention: Reply
Published on 2025-03-10 First Author Gregory G Schwartz
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer
Published on 2025-02-19 First Author Marc P Bonaca
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial
Published on 2025-02-19 First Author Rahul Aggarwal
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Published on 2025-02-17 First Author Rahul Aggarwal
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
Published on 2025-02-16 First Author Clara I Saldarriaga
Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome
Published on 2025-02-08 First Author Gregory G Schwartz
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials
Published on 2025-02-07 First Author Sina Rashedi
Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial
Published on 2025-02-06 First Author Gregory G Schwartz
Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery disease
Published on 2025-01-31 First Author Sanjay Divakaran
Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution
Published on 2025-01-29 First Author Doron Zahger
Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial
Published on 2025-01-27 First Author Connie N Hess
Reply: Where the Definition of Fragility Came From and Where It Will Go
Published on 2025-01-22 First Author Mario Enrico Canonico
Multidisciplinary Management of Chronic Limb Threatening Ischemia
Published on 2024-12-18 First Author Sivan Naveh
Relationship Between Left Ventricular Ejection Fraction and ICD-10 Codes Among Patients Hospitalized With Heart Failure
Published on 2024-12-17 First Author Ty J Gluckman
Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES
Published on 2024-12-17 First Author Gregory P Geba
Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study)
Published on 2024-12-12 First Author Dhanunjaya Lakkireddy
Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study
Published on 2024-11-21 First Author Irl B Hirsch
Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial
Published on 2024-11-18 First Author Steven E Nissen
Addressing Knowledge Gaps in Patients With High-Risk Peripheral Artery Disease
Published on 2024-11-11 First Author R Kevin Rogers
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial
Published on 2024-10-30 First Author Yogesh N V Reddy
Design and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making
Published on 2024-10-28 First Author Judith Hsia
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years
Published on 2024-10-26 First Author Neil A Goldenberg
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes
Published on 2024-10-18 First Author Marc P Bonaca
Is it time to get SIRIUS about in silico modelling of cardiovascular outcomes trials?
Published on 2024-10-08 First Author Marc P Bonaca
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
Published on 2024-09-11 First Author Ankeet S Bhatt
Trends in patient characteristics and mortality among Medicare patients diagnosed with peripheral artery disease
Published on 2024-09-09 First Author Xavier Fowler
Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions
Published on 2024-09-08 First Author Mario Enrico Canonico
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
Published on 2024-09-04 First Author Doron Zahger
A Novel Urology Preliminary Residency Curriculum Within a Department of Surgery for Unmatched Applicants
Published on 2024-09-02 First Author Tad A Manalo
Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement
Published on 2024-08-28 First Author Marc P Bonaca
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization
Published on 2024-08-21 First Author Mario Enrico Canonico
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials
Published on 2024-08-06 First Author Nicholas A Marston
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome
Published on 2024-07-22 First Author Marco Valgimigli
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review
Published on 2024-07-18 First Author Subodh Verma
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
Published on 2024-07-11 First Author Ellen M Apperloo
Rivaroxaban Versus Apixaban: A Comparison Without a Simple Solution
Published on 2024-07-08 First Author Marc Cohen
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study
Published on 2024-07-03 First Author Vera A Bittner
Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers
Published on 2024-06-27 First Author Cecilia C Low Wang
Migraine headache in patients with spontaneous coronary artery dissection: A report of the iSCAD Registry
Published on 2024-06-20 First Author Bryan J Wells
Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease
Published on 2024-06-19 First Author Connie N Hess
Association between tissue loss type and amputation risk among Medicare patients with concomitant diabetes and peripheral arterial disease
Published on 2024-06-16 First Author Aravind S Ponukumati
Co-Morbidity Differences Associated With Long-Term Amputation and Repeat Revascularization Rates After Femoropopliteal Artery Intervention for Intermittent Claudication by Sex, Race, and Ethnicity
Published on 2024-06-04 First Author S Elissa Altin
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published on 2024-05-16 First Author Writing Committee Members
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published on 2024-05-14 First Author Heather L Gornik
Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment
Published on 2024-05-14 First Author Manasi Tannu
Stepping Into the Future of Care for Patients With Peripheral Artery Disease
Published on 2024-05-14 First Author Marc P Bonaca
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD
Published on 2024-05-06 First Author Justin T Morrison
Medical Therapy for Peripheral Artery Disease
Published on 2024-05-02 First Author Mario Enrico Canonico
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19
Published on 2024-04-27 First Author Behnood Bikdeli
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
Published on 2024-04-24 First Author Marc P Bonaca
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Published on 2024-04-24 First Author Shaun G Goodman
Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial
Published on 2024-04-17 First Author Rahul Aggarwal
Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics?
Published on 2024-04-17 First Author Salwa J Zahalka
Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography
Published on 2024-04-12 First Author Nick S Nurmohamed
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial
Published on 2024-04-02 First Author Zhong Yuan